New HIV Drug May Top Sustiva

Saturday, November 2nd, 2013

A new HIV medication known as cenicriviroc has just successfully completed its Phase II trial, and the results seem to indicate a better performance than Sustiva and other drugs. The new dual CCR5/CCR2 inhibitor did have some problems in this trial, like a high dropout rate due to complicated dosing. However, investigators are now planning […]

Sustiva Linked to Increased Suicide Risk

Wednesday, October 9th, 2013

Recent data indicates that efavirenz (Sustiva) may be linked with an increased risk of suicidal tendencies in patients diagnosed with HIV. The data was presented by Katie Mollan, MS, from the University of North Carolina, Chapel Hill Center for AIDS Research. She said, “Efavirenz is widely used to treat HIV infection, but there is uncertainty […]